What's new

Human medicines European public assessment report (EPAR): Wainzua, eplontersen, Date of authorisation: 06/03/2025, Status: Authorised

Human medicines European public assessment report (EPAR): Wainzua, eplontersen, Date of authorisation: 06/03/2025, Status: Authorised

Mar 12, 2025 - 14:31
 0
Human medicines European public assessment report (EPAR): Wainzua, eplontersen, Date of authorisation: 06/03/2025, Status: Authorised
Human medicines European public assessment report (EPAR): Wainzua, eplontersen, Date of authorisation: 06/03/2025, Status: Authorised
Read More

Tags:

Previous Article

A 2,100% Markup: My Battle with a Vastly Overpriced Knee Brace — and U.S. Health...

Next Article

Breaking the 2,000V PV system threshold

Related Posts

Human medicines European public assessment report (EPAR): Piqray, alpelisib, Date of authorisation: 27/07/2020, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 12, 2025  0

Orphan designation: Lomitapide Treatment of familial chylomicronaemia, 17/12/2010 Positive

Orphan designation: Lomitapide Treatment of familial ch...

Feb 24, 2025  0

Orphan designation: Elraglusib Treatment of soft tissue sarcoma, 16/01/2025 Positive

Orphan designation: Elraglusib Treatment of soft tissue...

Feb 20, 2025  0